Case Study: How A Global Pharma Company Targeted a KOL Engagement Strategy Specific to Rheumatology
By leveraging real-time data feed from a variety of sources, pharma companies are more able to anticipate market access issues and develop plans for launching new drugs in key markets. This case study shows how one global pharma company is transforming rheumatology research with innovative approaches to drug development and trial planning, helping them secure a competitive edge in an increasingly complex market.
Complete the below form for immediate access to the case study.
H1 Case Study - How A Global Pharma Company Targeted a KOL Engagement Strategy Specific to Rheumatology
Visit h1.co for more information, or check out our profile.